In order to provide an alternative implant solution for those patients with poor medical preconditions, Prof. Nils-Claudius Gellrich, director of the clinic for oral and maxillofacial surgery at the Hannover Medical School in Germany, and Dr Björn Rahlf, senior physician for oral surgery at the same clinic, designed the IPS (individual patient solution) Implants Preprosthetic. In conversation with Dental Tribune International, Gellrich and Rahlf spoke about the patients for whom it is suitable and how they developed this individual implant.
LEEDS, UK: In a recently published consensus statement, leading cancer experts have discussed radiotherapy treatment options for rectal cancer during the COVID-19-pandemic. In their paper, they recommended a one-week course of radiotherapy and to delay surgery for patients with bowel cancer.
LONDON, UK: Since the outbreak of SARS-CoV-2 there have been speculations that the intake of non-steroidal anti-inflammatory drugs (NSAIDs) could worsen the course of COVID-19. However, a recent study conducted by researchers from King’s College London and Guy’s and St. Thomas NHS Foundation Trust (GSTT), has found that there is neither evidence for nor against the use of NSAIDs such as ibuprofen for patients infected with COVID-19.
GOTHENBURG, Sweden: A research team from Sahlgrenska University Hospital at the University of Gothenburg has, for the first time, transplanted a uterus from a deceased donor. The operation proceeded without complications and the recipient is doing well. The researchers plan to carry out another five transplants of a deceased donor’s uterus in the course of 2020 and 2021.
BERN/ZURICH, Switzerland: There is increasing evidence that health behaviour and disease manifestation differ substantially between women and men. The universities of Bern and Zurich are now offering the first continuing education program in sex- and gender-specific medicine in Switzerland. The program will start in May and aims to stimulate the implementation of sex- and gender-specific medicine in research and clinical practice. The course is unique in this form in Europe.
TUTTLINGEN, Germany/ZURICH, Switzerland: KARL STORZ, a leading endoscopy manufacturer, and VirtaMed, a world leader in medical training simulation, have introduced a novel mixed reality simulator bringing innovation to laparoscopic skills training.
GENEVA, Switzerland: Approximately one in 25 individuals—representing between 187 million and 280 million cases globally—undergoes major surgery annually for the treatment of disease, injury or illness. Although medical treatments are constantly evolving, postsurgical complications continue to represent a substantial burden for both patients and healthcare systems. A recent review investigated the correlation between smoking and postsurgical risks and found that tobacco smokers are at significantly higher risk than non-smokers for postsurgical complications.
AUGSBURG, Germany: Physicists at the University of Augsburg, in cooperation with scientists from the University Medical Center Hamburg-Eppendorf and the Technical University of Munich, have developed a new coating that releases antimicrobial ions. In the future, it could help prevent complications during the healing of endoprostheses.
ZURICH, Switzerland: Researchers from the University Hospital Zurich (UHZ), Swiss Federal Institute of Technology in Zurich (ETH Zurich), Wyss Zurich and the University of Zurich (UZH) have developed a machine that repairs injured human livers and keeps them alive outside the body for one week. This breakthrough may increase the number of available organs for transplantation.
BASEL, Switzerland/HELSINKI, Finland: Haematopoietic stem cell transplantation is used to treat cancers and severe blood and autoimmune diseases. Owing to slow immune system recovery after the transplantation, patients have a heightened risk of infection. However, a recent study has reported that the presence of acute or chronic oral foci of infection before the transplantation does not affect the patient’s survival rate within six months of the procedure.
OSLO, Norway: Aortic stenosis is caused by aortic valve calcification, a challenging condition for the health service and for affected patients. The only treatment currently available is surgery, which holds risks and challenges. Therefore, researchers from the University of Oslo have investigated possible pharmacological therapy options in order to develop a non-surgical treatment.
CLEVELAND, U.S.: Cleveland Clinic has become the first hospital in the world to successfully perform a robotic single-port kidney transplant, which enables all surgical instruments and the donor kidney to be placed through one small abdominal incision.
LEICESTER, UK: While short-term results of surgery are excellent, many patients fail to obtain long-term benefits the reasons for which remain unclear. Academics from the University of Leicester are researching why this is and have defined the top priorities for UK cardiac surgery research.
HEIDELBERG, Germany: A team from Heidelberg University Hospital and the German Cancer Research Centre has developed a new method for the automated image analysis of brain tumors. In their recent publication, the authors show that machine learning methods carefully trained on standard magnetic resonance imaging (MRI) are more reliable and precise than established radiological methods in the treatment of brain tumors. Thus, they make a valuable contribution to the individualised treatment of tumors. In addition, the validated method is an important first step towards the automated high-throughput analysis of medical image data of brain tumors.
LONDON, UK: A one-off operation that targets the nerves connected to the kidney has been found to maintain reduced blood pressure in hypertension patients for at least six months, according to the results of a clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust.
BASEL, Switzerland: The Oral Reconstruction Foundation has announced the theme and venue for its 2020 Oral Reconstruction Global Symposium. With a lineup of world-renowned speakers from all dental disciplines, the symposium, under the theme of “20/20 vision”, will take place from April 30 to May 2, 2020, at the Marriott Marquis hotel in New York City.
BALTIMORE, U.S.: For the first time, a person living with HIV has donated a kidney to a transplant recipient who is also HIV-positive. A multidisciplinary team from Johns Hopkins University School of Medicine recently completed the living donor HIV-to-HIV kidney transplant. This significant achievement could mean that many HIV-positive people will be helped with an organ donation in the future.
HOUSTON, U.S.: Patients who suffer loss of mandibular bone because of cancer, infection, trauma or congenital disease are left with bony defects that are both esthetically and functionally challenging. Researchers from Rice University have developed a technique to generate engineered tissue customized to the specific defect: implanting a 3-D printed bioreactor against a rib. The stem cells and blood vessels from the rib grow a natural bone material that is tailored to the patient and can be transplanted to the mandible.